There was an allegation of questionable elecsys ft4 iv assay results for 1 patient on a cobas e 801 module compared to an abbott analyzer.On (b)(6) 2023, the initial ft4 result was 2.34 ng/ml.On (b)(6) 2023, the sample was sent to another laboratory for testing on an abbott analyzer.The ft4 result was 1.45 ng/dl.The reference ranges were requested but not provided.The abbott results were deemed more in accordance with the patient's clinical picture.
|
The patient sample was provided for investigation.It was found that the patient is taking levothyroxine.Per product labeling, "the drugs furosemide, carbamazepine, phenytoin and levothyroxine sodium (l-t4, synthetic levothyroxine 13) caused elevated ft4 recovery at the daily therapeutic concentration." the investigation determined that the ft4 result differences generated between the different methods are consistent with methodological differences.No product problem was identified.
|